According to this CBS report, researchers at the University of Maryland’s School of Medicine have begun testing experimental COVID-19 vaccine candidates developed by Pfizer and BioNTech.

The report says the research is being funded by Pfizer Inc. and will study the safety, efficacy, and dosing of an experimental mRNA -based vaccine.

The vaccine research is being conducted in the UMSOM Center for Vaccine Development and Global Health, and it is part of a multicenter study in the U.S. and in Germany that will include up to 360 participants in this initial stage.

For individuals in the Washington area interested in participating in this important vaccine trial: Call 1 (410) 706-6156, text COVID19Vaccine to #555888, email, or click here.